• Dépistage, diagnostic, pronostic

  • Découverte de technologies et de biomarqueurs

  • Appareil digestif (autre)

Identifying patients with undiagnosed small intestinal neuroendocrine tumours in primary care using statistical and machine learning: model development and validation study

Menée au Royaume-Uni à partir de données 2000-2023 de l'"Optimum Patient Care Research Database" portant sur 11,7 millions de patients, cette étude évalue la performance d'algorithmes d'apprentissage automatique utilisant des données de médecine générale pour identifier des patients atteints d'une tumeur neuroendocrine de l'intestin grêle pas encore diagnostiquée

Background : Neuroendocrine tumours (NETs) are increasing in incidence, often diagnosed at advanced stages, and individuals may experience years of diagnostic delay, particularly when arising from the small intestine (SI). Clinical prediction models could present novel opportunities for case finding in primary care.

Methods : An open cohort of adults (18+ years) contributing data to the Optimum Patient Care Research Database between 1st Jan 2000 and 30th March 2023 was identified. This database collects de-identified data from general practices in the UK. Model development approaches comprised logistic regression, penalised regression, and XGBoost. Performance (discrimination and calibration) was assessed using internal-external cross-validation. Decision analysis curves compared clinical utility.

Results : Of 11.7 million individuals, 382 had recorded SI NET diagnoses (0.003%). The XGBoost model had the highest AUC (0.869, 95% confidence interval [CI]: 0.841–0.898) but was mildly miscalibrated (slope 1.165, 95% CI: 1.088–1.243; calibration-in-the-large 0.010, 95% CI:

0.164 to 0.185). Clinical utility was similar across all models.

Discussion : Multivariable prediction models may have clinical utility in identifying individuals with undiagnosed SI NETs using information in their primary care records. Further evaluation including external validation and health economics modelling may identify cost-effective strategies for case finding for this uncommon tumour.

British Journal of Cancer , article en libre accès, 2024

Voir le bulletin